Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      DoP invites nominations for 5th India Pharma and Medical Device Awards

      DoP invites nominations for 5th India Pharma and Medical Device Awards

      Medical Dialogues Bureau4 Nov 2019 5:23 PM IST
      New Delhi: The Government of India, Ministry of Chemicals & Fertilizers, Department of Pharmaceuticals (DoP) has decided to confer 5th India...
      Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA

      Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA

      Medical Dialogues Bureau4 Nov 2019 4:31 PM IST
      New Delhi: Drug firm, Strides Pharma recently announced that the USFDA issued a statement1 on November 1, 2019, providing an update with the latest...
      Medtronic launches Valiant Navion Thoracic Stent Graft System in Japan

      Medtronic launches Valiant Navion Thoracic Stent Graft System in Japan

      Medical Dialogues Bureau4 Nov 2019 9:30 AM IST
      In its recent press release, Medtronic said, "The low-profile Valiant Navion system is built to further improve upon the performance of the...
      GSK Benlysta gets European nod for treatment of children with lupus

      GSK Benlysta gets European nod for treatment of children with lupus

      Medical Dialogues Bureau4 Nov 2019 9:15 AM IST
      New Delhi: GlaxoSmithKline (GSK) plc recently announced that the European Commission has adopted a decision to extend to children five years and...
      AbbVie says multiple parties vying for assets related to Allergan deal approval

      AbbVie says multiple parties vying for assets related to Allergan deal approval

      Medical Dialogues Bureau4 Nov 2019 9:00 AM IST
      AbbVie Inc said it had notified the U.S. antitrust watchdog of its intention to divest its experimental inflammatory bowel disease therapy,...
      CDSCO, Saudi Food and Drug Authority ink agreement for medical products regulations

      CDSCO, Saudi Food and Drug Authority ink agreement for medical products regulations

      Medical Dialogues Bureau3 Nov 2019 10:24 AM IST
      An MoU was signed between the Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare and Saudi Food and Drug...
      Indoco Remedies gets USFDA ANDA nod for Glycopyrrolate Injection

      Indoco Remedies gets USFDA ANDA nod for Glycopyrrolate Injection

      Medical Dialogues Bureau3 Nov 2019 10:00 AM IST
      Glycopyrrolate is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the...
      Stempeutics gets patent for stem cell drug Stempeucel from US Patent and Trademarks Office

      Stempeutics gets patent for stem cell drug Stempeucel from US Patent and Trademarks Office

      Medical Dialogues Bureau3 Nov 2019 9:55 AM IST
      "The US patent is for the method of treating ischemia by administering pooled allogeneic mesenchymal stromal cells," Stempeutics Research said in a...
      Another delay in USD 2.1 million gene therapy Zolgensma data reporting, Novartis admits mistake

      Another delay in USD 2.1 million gene therapy Zolgensma data reporting, Novartis admits mistake

      Medical Dialogues Bureau3 Nov 2019 9:45 AM IST
      The USFDA on Wednesday placed a partial hold on a Novartis trial of the $2.1 million-per-patient gene therapy, Zolgensma after the company informed...
      Dr Reddys Q2 revenue up 26.4 pc to Rs 4801 crore

      Dr Reddys Q2 revenue up 26.4 pc to Rs 4801 crore

      Medical Dialogues Bureau3 Nov 2019 9:30 AM IST
      Revenue in the second quarter stood at Rs 4,800.9 crore as against Rs 3,797.8 crore in the year-ago period, an increase of 26.41 per cent, Dr Reddy's...
      Amgen to reduce price of its cholesterol drug Repatha starting 2020

      Amgen to reduce price of its cholesterol drug Repatha starting 2020

      Medical Dialogues Bureau3 Nov 2019 9:15 AM IST
      Amgen launched the lower-price option of Repatha last October, selling the drug to some patients under the list price of $5,850 per year because the...
      Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial

      Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial

      Medical Dialogues Bureau3 Nov 2019 9:00 AM IST
      Bristol-Myers Squibb said its therapies when administered alongside two courses of chemotherapy demonstrated superior overall survival compared to...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok